{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:27:12Z","timestamp":1759336032636,"version":"build-2065373602"},"reference-count":95,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["5\/13\/49\/2018\/NCD-III"],"award-info":[{"award-number":["5\/13\/49\/2018\/NCD-III"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.humimm.2023.110748","type":"journal-article","created":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T03:36:10Z","timestamp":1704339370000},"page":"110748","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Elevated levels of peripheral Th17 cells and Th17-related cytokines in patients with periampullary adenocarcinoma"],"prefix":"10.1016","volume":"85","author":[{"given":"Imteyaz Ahmad","family":"Khan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nidhi","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepak","family":"Gunjan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nihar Ranjan","family":"Dash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baibaswata","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surabhi","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3921-6752","authenticated-orcid":false,"given":"Anoop","family":"Saraya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humimm.2023.110748_b0005","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.amsu.2020.07.059","article-title":"Prognostic factors for long-term survival after pancreaticoduodenectomy for periampullary adenocarcinoma. A retrospective cohort study","volume":"57","author":"Zakaria","year":"2020","journal-title":"Ann. Med. Surg. (Lond)"},{"key":"10.1016\/j.humimm.2023.110748_b0010","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/1471-2407-8-251","article-title":"Ampullary adenocarcinoma \u2013 differentiation matters","volume":"8","author":"Schirmacher","year":"2008","journal-title":"BMC Cancer"},{"key":"10.1016\/j.humimm.2023.110748_b0015","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/hpb.12071","article-title":"Longterm survival after pancreaticoduodenectomy for periampullary adenocarcinomas","volume":"15","author":"Chen","year":"2013","journal-title":"HPB"},{"key":"10.1016\/j.humimm.2023.110748_b0020","doi-asserted-by":"crossref","first-page":"634","DOI":"10.4240\/wjgs.v8.i9.634","article-title":"Total pancreatectomy: short- and long-term outcomes at a high-volume pancreas center","volume":"8","author":"Zakaria","year":"2016","journal-title":"World J. Gastrointestinal Surg."},{"key":"10.1016\/j.humimm.2023.110748_b0025","first-page":"7","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"CA: A Cancer J. Clin."},{"key":"10.1016\/j.humimm.2023.110748_b0030","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1097\/00000658-199806000-00005","article-title":"Periampullary adenocarcinoma: analysis of 5-year survivors","volume":"227","author":"Yeo","year":"1998","journal-title":"Ann. Surg."},{"key":"10.1016\/j.humimm.2023.110748_b0035","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/01.sla.0000150166.94732.88","article-title":"Actual long-term outcome of extrahepatic bile duct cancer after surgical resection","volume":"241","author":"Jang","year":"2005","journal-title":"Ann. Surg."},{"key":"10.1016\/j.humimm.2023.110748_b0040","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/1748-717X-6-126","article-title":"Evaluation of adjuvant chemoradiation therapy for ampullary adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative study","volume":"6","author":"Narang","year":"2011","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.humimm.2023.110748_b0045","article-title":"Role of adjuvant chemoradiotherapy for ampulla of Vater cancer","volume":"75","author":"Kim","year":"2009","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.humimm.2023.110748_b0050","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/jso.21390","article-title":"Survival analysis after pancreatic resection for ampullary and pancreatic head carcinoma: an analysis of clinicopathological factors","volume":"100","author":"Sommerville","year":"2009","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.humimm.2023.110748_b0055","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/jso.24048","article-title":"Has survival following pancreaticoduodenectomy for pancreas adenocarcinoma improved over time?","volume":"112","author":"Salem","year":"2015","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.humimm.2023.110748_b0060","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/s41423-018-0004-4","article-title":"When worlds collide: Th17 and Treg cells in cancer and autoimmunity","volume":"15","author":"Knochelmann","year":"2018","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.humimm.2023.110748_b0065","article-title":"Th17 cells in autoimmune and infectious diseases","volume":"2014","author":"Zambrano-Zaragoza","year":"2014","journal-title":"Int. J. Inflam."},{"key":"10.1016\/j.humimm.2023.110748_b0070","doi-asserted-by":"crossref","first-page":"e8797683","DOI":"10.1155\/2020\/8797683","article-title":"Th17 cells and IL-17 as novel immune targets in ovarian cancer therapy","volume":"2020","author":"Bilska","year":"2020","journal-title":"J. Oncol."},{"issue":"69","key":"10.1016\/j.humimm.2023.110748_b0075","first-page":"142","article-title":"Basic biology and role of interleukin-17 in immunity and inflammation","volume":"2015","author":"Zenobia","year":"2000","journal-title":"Periodontol"},{"key":"10.1016\/j.humimm.2023.110748_b0080","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41577-022-00746-9","article-title":"IL-17 and IL-17-producing cells in protection versus pathology","volume":"23","author":"Mills","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.humimm.2023.110748_b0085","first-page":"37","article-title":"IL-17 promotes tumor angiogenesis through Stat3 pathway mediated upregulation of VEGF in gastric cancer","author":"Wu","year":"2016","journal-title":"Tumour Biol.: J. Int. Soc. Oncodev. Biol. Med."},{"key":"10.1016\/j.humimm.2023.110748_b0090","doi-asserted-by":"crossref","first-page":"Available","DOI":"10.3389\/fimmu.2021.637829","article-title":"Role of the IL-23\/IL-17 pathway in rheumatic diseases: an overview","volume":"12","author":"Schinocca","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2023.110748_b0095","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/978-3-030-55617-4_6","article-title":"IL-23 and the tumor microenvironment","volume":"1290","author":"Subhadarshani","year":"2021","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.humimm.2023.110748_b0100","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ajg.2019.05.002","article-title":"Diagnostic and prognostic value of serum IL-23 in colorectal cancer","volume":"20","author":"Elessawi","year":"2019","journal-title":"Arab. J. Gastroenterol."},{"key":"10.1016\/j.humimm.2023.110748_b0105","first-page":"4639","article-title":"Aberrant expression of IL-23\/IL-23R in patients with breast cancer and its clinical significance","volume":"17","author":"Sheng","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.humimm.2023.110748_b0110","doi-asserted-by":"crossref","first-page":"7424","DOI":"10.3390\/ijms12117424","article-title":"Distribution and clinical significance of Th17 cells in the tumor microenvironment and peripheral blood of pancreatic cancer patients","volume":"12","author":"He","year":"2011","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.humimm.2023.110748_b0115","first-page":"1271","article-title":"Tumor-infiltrating CD4+ Th17 cells produce IL-17 in tumor microenvironment and promote tumor progression in human gastric cancer","volume":"25","author":"Iida","year":"2011","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.humimm.2023.110748_b0120","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.immuni.2009.02.007","article-title":"Critical regulation of early Th17 cell differentiation by IL-1 signaling","volume":"30","author":"Chung","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.humimm.2023.110748_b0125","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.cell.2006.07.035","article-title":"The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells","volume":"126","author":"Ivanov","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.humimm.2023.110748_b0130","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12935-022-02528-8","article-title":"The role of Th17 cells in the pathogenesis and treatment of breast cancer","volume":"22","author":"Karpisheh","year":"2022","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.humimm.2023.110748_b0135","doi-asserted-by":"crossref","first-page":"e26617","DOI":"10.4161\/onci.26617","article-title":"Role of TH17 cytokines in the control of colorectal cancer","volume":"2","author":"De Simone","year":"2013","journal-title":"Oncoimmunology."},{"key":"10.1016\/j.humimm.2023.110748_b0140","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/cmi.2010.5","article-title":"Th17 cells and their associated cytokines in liver diseases","volume":"7","author":"Lafdil","year":"2010","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.humimm.2023.110748_b0145","first-page":"249","article-title":"Th17 cells promote tumor growth in an immunocompetent orthotopic mouse model of prostate cancer","volume":"7","author":"Duan","year":"2019","journal-title":"Am. J. Clin. Exp. Urol."},{"key":"10.1016\/j.humimm.2023.110748_b0150","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nri2742","article-title":"TH17 cells in tumour immunity and immunotherapy","volume":"10","author":"Zou","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.humimm.2023.110748_b0155","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s12272-019-01146-9","article-title":"T helper 17 (Th17) cells and interleukin-17 (IL-17) in cancer","volume":"42","author":"Chang","year":"2019","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.humimm.2023.110748_b0160","doi-asserted-by":"crossref","first-page":"e984539","DOI":"10.4161\/2162402X.2014.984539","article-title":"Angels and demons: Th17 cells represent a beneficial response, while neutrophil IL-17 is associated with poor prognosis in squamous cervical cancer","volume":"4","author":"Punt","year":"2015","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.humimm.2023.110748_b0165","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1158\/1078-0432.CCR-07-5164","article-title":"Phenotypic analysis of prostate-infiltrating lymphocytes reveals TH17 and treg skewing","volume":"14","author":"Sfanos","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.humimm.2023.110748_b0170","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1182\/blood-2009-03-208249","article-title":"Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments","volume":"114","author":"Kryczek","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2023.110748_b0175","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1158\/0008-5472.CAN-10-2907","article-title":"Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer","volume":"71","author":"Tosolini","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.humimm.2023.110748_b0180","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/eji.200838475","article-title":"Th17 cells promote pancreatic inflammation but only induce diabetes efficiently in lymphopenic hosts after conversion into Th1 cells","volume":"39","author":"Martin-Orozco","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.humimm.2023.110748_b0185","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.4049\/jimmunol.0902609","article-title":"Induction of Th17 cells in the tumor microenvironment improves survival in a murine model of pancreatic cancer","volume":"185","author":"Gnerlich","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.humimm.2023.110748_b0190","doi-asserted-by":"crossref","first-page":"6032","DOI":"10.1038\/sj.onc.1205897","article-title":"Apo2L\/TRAIL differentially modulates the apoptotic effects of sulindac and a COX-2 selective non-steroidal anti-inflammatory agent in Bax-deficient cells","volume":"21","author":"He","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.humimm.2023.110748_b0195","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00251-023-01318-4","article-title":"Increased circulating Th17 cell populations in patients with pancreatic ductal adenocarcinoma","volume":"75","author":"Khan","year":"2023","journal-title":"Immunogenetics"},{"key":"10.1016\/j.humimm.2023.110748_b0200","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12865-021-00431-x","article-title":"Serum IL-35 is decreased in overweight patients with rheumatoid arthritis: its correlation with Th1\/Th2\/Th17-related cytokines","volume":"22","author":"Li","year":"2021","journal-title":"BMC Immunol."},{"key":"10.1016\/j.humimm.2023.110748_b0205","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/gene.2011.85","article-title":"A novel isoform of the orphan receptor ROR\u03b3t suppresses IL-17 production in human T cells","volume":"13","author":"Rauen","year":"2012","journal-title":"Genes Immun."},{"key":"10.1016\/j.humimm.2023.110748_b0210","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12881-017-0434-3","article-title":"Signal transducer and activator of transcription 3 (STAT3) promoter methylation and expression in pituitary adenoma","volume":"18","author":"Valiulyte","year":"2017","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.humimm.2023.110748_b0215","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12885-017-3957-2","article-title":"Regulation of pancreatic stellate cell activation by Notch3","volume":"18","author":"Song","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.humimm.2023.110748_b0220","unstructured":"Fernandez-Cruz L. Periampullary carcinoma. Surgical Treatment: Evidence-Based and Problem-Oriented. Zuckschwerdt; 2001. Available: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK6924\/."},{"key":"10.1016\/j.humimm.2023.110748_b0225","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.hbpd.2018.08.004","article-title":"Predictors of long-term survival after pancreaticoduodenectomy for peri-ampullary adenocarcinoma: a retrospective study of 5-year survivors","volume":"17","author":"El Nakeeb","year":"2018","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"10.1016\/j.humimm.2023.110748_b0230","first-page":"5","article-title":"Th17 cells in cancer: the ultimate identity crisis","author":"Bailey","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2023.110748_b0235","doi-asserted-by":"crossref","unstructured":"Th17 cells in cancer: help or hindrance? | Carcinogenesis | Oxford Academic. [cited 15 May 2023]. Available: https:\/\/academic.oup.com\/carcin\/article\/32\/5\/643\/2896659.","DOI":"10.1093\/carcin\/bgr019"},{"key":"10.1016\/j.humimm.2023.110748_b0240","unstructured":"JCI - Th9 and Th17 cells: the controversial twins in cancer immunity. [cited 15 May 2023]. Available: https:\/\/www.jci.org\/articles\/view\/138418."},{"key":"10.1016\/j.humimm.2023.110748_b0245","unstructured":"JCI - Microenvironmental Th9 and Th17 lymphocytes induce metastatic spreading in lung cancer. [cited 15 May 2023]. Available: https:\/\/www.jci.org\/articles\/view\/124037."},{"key":"10.1016\/j.humimm.2023.110748_b0250","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.immuni.2014.03.013","article-title":"\u03b3\u03b4T17 cells promote the accumulation and expansion of myeloid-derived suppressor cells in human colorectal cancer","volume":"40","author":"Wu","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.humimm.2023.110748_b0255","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.jhep.2008.12.033","article-title":"Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients","volume":"50","author":"Zhang","year":"2009","journal-title":"J. Hepatol."},{"key":"10.1016\/j.humimm.2023.110748_b0260","doi-asserted-by":"crossref","first-page":"e20190354","DOI":"10.1084\/jem.20190354","article-title":"Interleukin-17\u2013induced neutrophil extracellular traps mediate resistance to checkpoint blockade in pancreatic cancer","volume":"217","author":"Zhang","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.humimm.2023.110748_b0265","first-page":"5702","article-title":"Changes of Th17\/Treg cell and related cytokines in pancreatic cancer patients","volume":"8","author":"Wang","year":"2015","journal-title":"Int. J. Clin. Exp. Path."},{"key":"10.1016\/j.humimm.2023.110748_b0270","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s12032-013-0461-7","article-title":"Imbalance in the Th17\/Treg and cytokine environment in peripheral blood of patients with adenocarcinoma and squamous cell carcinoma","volume":"30","author":"Zhao","year":"2013","journal-title":"Med. Oncol."},{"key":"10.1016\/j.humimm.2023.110748_b0275","doi-asserted-by":"crossref","unstructured":"Lu T, Yu S, Liu Y, Yin C, Ye J, Liu Z, et al. Aberrant Circulating Th17 Cells in Patients with B-Cell Non-Hodgkin\u2019s Lymphoma. In: Bertolini F, editor. PLoS ONE. 2016;11:e0148044. https:\/\/doi.org\/10.1371\/journal.pone.0148044.","DOI":"10.1371\/journal.pone.0148044"},{"key":"10.1016\/j.humimm.2023.110748_b0280","doi-asserted-by":"crossref","first-page":"6730","DOI":"10.4049\/jimmunol.178.11.6730","article-title":"Cutting edge: Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment","volume":"178","author":"Kryczek","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.humimm.2023.110748_b0285","unstructured":"Zhao J, Chen X, Herjan T, Li X. The role of interleukin-17 in tumor development and progression. J. Experimental Med."},{"key":"10.1016\/j.humimm.2023.110748_b0290","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s12029-015-9787-z","article-title":"Evaluation of Serum Interleukin-17 (IL-17) levels as a diagnostic marker in pancreatic adenocarcinoma","volume":"47","author":"Karabulut","year":"2016","journal-title":"J. Gastrointest. Cancer"},{"key":"10.1016\/j.humimm.2023.110748_b0295","doi-asserted-by":"crossref","first-page":"16053","DOI":"10.1038\/srep16053","article-title":"Interleukin-17 promotes angiogenesis by stimulating VEGF production of cancer cells via the STAT3\/GIV signaling pathway in non-small-cell lung cancer","volume":"5","author":"Pan","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.humimm.2023.110748_b0300","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1172\/JCI39065","article-title":"The tumor-promoting actions of TNF-alpha involve TNFR1 and IL-17 in ovarian cancer in mice and humans","volume":"119","author":"Charles","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.humimm.2023.110748_b0305","first-page":"1065","article-title":"IL-17A promotes CXCR2-dependent angiogenesis in a mouse model of liver cancer","volume":"20","author":"Liu","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.humimm.2023.110748_b0310","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.bbrc.2008.07.060","article-title":"The prevalence of Th17 cells in patients with gastric cancer","volume":"374","author":"Zhang","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.humimm.2023.110748_b0315","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/his.12156","article-title":"Interleukin-17-producing cell infiltration in the breast cancer tumour microenvironment is a poor prognostic factor","volume":"63","author":"Chen","year":"2013","journal-title":"Histopathology"},{"key":"10.1016\/j.humimm.2023.110748_b0320","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3109\/1354750X.2014.908954","article-title":"Serum interleukin-17 as a diagnostic and prognostic marker for non-small cell lung cancer","volume":"19","author":"Xu","year":"2014","journal-title":"Biomarkers"},{"key":"10.1016\/j.humimm.2023.110748_b0325","first-page":"3258","article-title":"Prognostic significance of interleukin 17 in cancer: a meta-analysis","volume":"7","author":"Zhang","year":"2014","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.humimm.2023.110748_b0330","unstructured":"ROR\u03b3t inhibition selectively targets IL-17 producing iNKT and \u03b3\u03b4-T cells enriched in Spondyloarthritis patients - PubMed. [cited 17 May 2023]. Available: https:\/\/pubmed.ncbi.nlm.nih.gov\/30602780\/."},{"key":"10.1016\/j.humimm.2023.110748_b0335","unstructured":"Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis - PubMed. [cited 17 May 2023]. Available: https:\/\/pubmed.ncbi.nlm.nih.gov\/17187052\/."},{"key":"10.1016\/j.humimm.2023.110748_b0340","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nature04808","article-title":"IL-23 promotes tumour incidence and growth","volume":"442","author":"Langowski","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.humimm.2023.110748_b0345","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.micinf.2009.04.003","article-title":"IL-17 and Th17 cells in human inflammatory diseases","volume":"11","author":"Miossec","year":"2009","journal-title":"Microbes Infect."},{"key":"10.1016\/j.humimm.2023.110748_b0350","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1600-065X.2008.00628.x","article-title":"Th17 cells in human disease","volume":"223","author":"Tesmer","year":"2008","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.humimm.2023.110748_b0355","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","article-title":"IL-17 and Th17 Cells","volume":"27","author":"Korn","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.humimm.2023.110748_b0360","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/623759","article-title":"The role of interleukin 17 in tumour proliferation, angiogenesis, and metastasis","volume":"2014","author":"Yang","year":"2014","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.humimm.2023.110748_b0365","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.immuni.2010.08.013","article-title":"\u03b3\u03b4 T cells enhance autoimmunity by restraining regulatory T cell responses via an interleukin-23-dependent mechanism","volume":"33","author":"Petermann","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.humimm.2023.110748_b0370","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.immuni.2009.08.001","article-title":"Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity","volume":"31","author":"Sutton","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.humimm.2023.110748_b0375","doi-asserted-by":"crossref","first-page":"e106834","DOI":"10.1371\/journal.pone.0106834","article-title":"Intratumor IL-17-positive mast cells are the major source of the IL-17 that is predictive of survival in gastric cancer patients","volume":"9","author":"Liu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.humimm.2023.110748_b0380","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1053\/j.gastro.2012.06.010","article-title":"CD8(+) T cells that produce interleukin-17 regulate myeloid-derived suppressor cells and are associated with survival time of patients with gastric cancer","volume":"143","author":"Zhuang","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.humimm.2023.110748_b0385","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.biopha.2018.04.147","article-title":"Analysis of Th22, Th17 and CD4+cells co-producing IL-17\/IL-22 at different stages of human colon cancer","volume":"103","author":"Doulabi","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.humimm.2023.110748_b0390","unstructured":"Th17 cell frequency and IL-17A production in peripheral blood of patients with non-small-cell lung cancer - Gang Chen, Pei-Gang Zhang, Jun-Sheng Li, Jing-Jing Duan, Wen Su, Shi-Ping Guo, Yan-Feng Wang, Jun-Ning Sun, Xiao-Tang Yang, 2020. [cited 17 May 2023]. Available: https:\/\/journals.sagepub.com\/doi\/full\/10.1177\/0300060520925948."},{"key":"10.1016\/j.humimm.2023.110748_b0395","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.immuni.2011.12.019","article-title":"Stat3 and Gfi-1 transcription factors control Th17 Cell immunosuppressive activity via the regulation of ectonucleotidase expression","volume":"36","author":"Chalmin","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.humimm.2023.110748_b0400","doi-asserted-by":"crossref","first-page":"8228","DOI":"10.1158\/1078-0432.CCR-08-1329","article-title":"The incidence, correlation with tumor-infiltrating inflammation, and prognosis of phosphorylated STAT3 expression in human gliomas","volume":"14","author":"Abou-Ghazal","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.humimm.2023.110748_b0405","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4137\/TOG.S1903","article-title":"A STAT3 gene expression signature in gliomas is associated with a poor prognosis","volume":"2","author":"Alvarez","year":"2007","journal-title":"Transl. Oncogenomics."},{"key":"10.1016\/j.humimm.2023.110748_b0410","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1002\/ijc.29923","article-title":"Constitutive activation of STAT3 in breast cancer cells: a review","volume":"138","author":"Banerjee","year":"2016","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.humimm.2023.110748_b0415","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3390\/ijms22020603","article-title":"The multifaced role of STAT3 in cancer and its implication for anticancer therapy","volume":"22","author":"Tolomeo","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.humimm.2023.110748_b0420","doi-asserted-by":"crossref","first-page":"e421821","DOI":"10.1155\/2013\/421821","article-title":"Role of STAT3 in cancer metastasis and translational advances","volume":"2013","author":"Kamran","year":"2013","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.humimm.2023.110748_b0425","doi-asserted-by":"crossref","first-page":"5407126","DOI":"10.1155\/2019\/5407126","article-title":"Hepatitis B Virus X protein-induced ROR\u03b3 expression to promote the migration and proliferation of hepatocellular carcinoma","volume":"2019","author":"Huang","year":"2019","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.humimm.2023.110748_b0430","unstructured":"Frontiers | Retinoic Acid Receptor-Related Orphan Receptors: Critical Roles in Tumorigenesis. [cited 18 May 2023]. Available: https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2018.01187\/full."},{"key":"10.1016\/j.humimm.2023.110748_b0435","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/nm.4070","article-title":"ROR-\u03b3 drives androgen receptor expression and represents a therapeutic target in castration-resistant prostate cancer","volume":"22","author":"Wang","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.humimm.2023.110748_b0440","doi-asserted-by":"crossref","first-page":"3508","DOI":"10.1158\/1078-0432.CCR-18-3185","article-title":"Phase 1 open-label, multicenter study of first-in-class ROR\u03b3 agonist LYC-55716 (Cintirorgon): safety, tolerability, and preliminary evidence of antitumor activity","volume":"25","author":"Mahalingam","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.humimm.2023.110748_b0445","doi-asserted-by":"crossref","first-page":"897","DOI":"10.3892\/ol.2016.4729","article-title":"Melatonin downregulates nuclear receptor RZR\/ROR\u03b3 expression causing growth-inhibitory and anti-angiogenesis activity in human gastric cancer cells in vitro and in vivo","volume":"12","author":"Wang","year":"2016","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.humimm.2023.110748_b0450","doi-asserted-by":"crossref","first-page":"e0181868","DOI":"10.1371\/journal.pone.0181868","article-title":"ROR\u03b3t and ROR\u03b1 signature genes in human Th17 cells","volume":"12","author":"Castro","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.humimm.2023.110748_b0455","unstructured":"Prevalence and clinical relevance of Th17 cells in patients with gastric cancer - PubMed. [cited 27 May 2023]. Available: https:\/\/pubmed.ncbi.nlm.nih.gov\/22940035\/."},{"key":"10.1016\/j.humimm.2023.110748_b0460","doi-asserted-by":"crossref","first-page":"e60444","DOI":"10.1371\/journal.pone.0060444","article-title":"Increased circulating Th17 cells after transarterial chemoembolization correlate with improved survival in stage III hepatocellular carcinoma: a prospective study","volume":"8","author":"Liao","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.humimm.2023.110748_b0465","doi-asserted-by":"crossref","first-page":"6348","DOI":"10.4049\/jimmunol.1001728","article-title":"Generation and differentiation of IL-17-producing CD4+ T cells in malignant pleural effusion","volume":"185","author":"Ye","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.humimm.2023.110748_b0470","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1182\/blood-2007-11-120998","article-title":"Tumor-specific Th17-polarized cells eradicate large established melanoma","volume":"112","author":"Muranski","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2023.110748_b0475","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1192303","article-title":"The protective and pathogenic role of Th17 cell plasticity and function in the tumor microenvironment","volume":"14","author":"Pan","year":"2023","journal-title":"Front. Immunol."}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885923003841?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885923003841?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:58:54Z","timestamp":1759319934000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885923003841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":95,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0198885923003841"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2023.110748","relation":{},"ISSN":["0198-8859"],"issn-type":[{"type":"print","value":"0198-8859"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elevated levels of peripheral Th17 cells and Th17-related cytokines in patients with periampullary adenocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2023.110748","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110748"}}